PDSB PDS Biotechnology Net earnings per share growth this year

PDSB (pdsbiotech.com) - company brandmark

PDS Biotechnology is implementing automated biomolecule screening to accelerate drug development. PDS Biotechnology is recognized as an expert in activating T-cells against tumors. Examining the annual EPS change on GURU.Markets, it is evident that the value 42.00 captures the metric level. The issuer's strategy relies on expanding the Versamune pipeline and developing B2B partnerships to capture the oncology market.

PDS Biotechnology Corporation (PDSB): Net earnings per share growth this year from 07/04/2022 to 11/12/2026

Analytical breakdowns and data insights for company pdsbiotech.com (PDSB)

- current quotes and average value forecast:
Market Chart PDS Biotechnology Corporation|PDSB - Price Target Chart
- market capitalization data:
Market Valuation PDS Biotechnology Corporation|PDSB - Total Company Value
- company book value details:
Accounting Value per Share PDS Biotechnology|PDSB - Company Net Assets|Market Capitalization to Book Value Ratio pdsbiotech.com|PDSB - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio PDS Biotechnology|PDSB - Long-Term Debt to Equity|Current Liabilities to Capital PDS Biotechnology Corporation|PDSB - Company Total Debt|Debt to Net Assets PDS Biotechnology Corporation|PDSB - Company Long-Term Liabilities|Amount of Current Liabilities PDS Biotechnology|Intermediate Coverage Ratio pdsbiotech.com
- net income and valuation ratios data:
PDSB - Net Profit|Expected Net Profit PDS Biotechnology|PDSB - Price to Earnings Ratio|Future Price to Earnings Multiple PDS Biotechnology Corporation|PDSB - PEG Multiple|EV/EBITDA Multiple PDS Biotechnology Corporation|PDSB - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months PDS Biotechnology|PDSB - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months pdsbiotech.com|PDSB - Earnings per share growth in current year|Net earnings per share change forecast for next year PDS Biotechnology
Summary company analysis:PDSB (PDS Biotechnology Corp)
Brand item of PDS Biotechnology

This indicator reflects the dynamics of net earnings per share compared to the same period last year. By analyzing the annual EPS growth metric, an investor assesses the actual scaling speed of the business. The calculation is based on the difference between current and past financial results, excluding reporting time lags. For PDS Biotechnology (PDSB), this figure confirms the effectiveness of investments in bioethical developments and transparent management. Stable EPS growth here indicates the commercialization of safe immuno-oncology solutions.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year Immunocore PLC|Net earnings per share growth this year Janux Corp (JANX)|Earnings per share growth in current year Arcus Biosciences, Inc. (RCUS)|Net earnings per share growth this year zymeworks.com ZYME|Tango Therapeutics, Inc. - Net earnings per share growth this year|Earnings growth in current year Iovance Biotherapeutics Inc IOVA|IMTX - Earnings per share growth in current year|XNCR (Xencor Inc.) - Earnings per share growth this year|Compass Therapeutics (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year replimune.com (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech, Inc.)|Earnings per share increase in current year STRO|MiNK Therapeutics - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics|immixbio.com (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings Inc. - Earnings per share increase in current year|CUE (Cue Biopharma, Inc.) - Earnings growth in current year|Earnings growth in current year Sonnet BioTherapeutics Holdings Inc.|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|NextCure Corporation (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Earnings per share trend in current year INTS|SNSE: Earnings growth in current year|Earnings per share growth this year TOVX|Earnings per share growth in current year Gritstone bio Inc.|Kineta Corp (KA) - Expected net earnings per share growth this year|Net earnings per share growth this year NEXI (NexImmune, Inc.)|TSBX (turnstonebio.com) - Earnings per share increase in current year|Earnings growth in current year VCNX (Vaccinex)|Harpoon Therapeutics Inc - Earnings per share growth in current year